CoChat

Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited

Open access
Braun, Leah T, Vogel, Frederick, Zopp, Stephanie, Marchant Seiter, Thomas, Rubinstein, German, Berr, Christina M, Künzel, Heike, Beuschlein, Felix, Reincke, Martin · 2022 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Context: Cushing syndrome (CS) is a rare and serious disease with high mortality. Patients are often diagnosed late in the course of the disease. Objective: This work investigated whether defined patient populations should be screened outside the at-risk populations defined in current guidelines. Methods: As part of the prospective German Cushing registry, we studied 377 patients with suspected CS. The chief complaint for CS referral was documented. Using urinary free cortisol, late-night salivary cortisol, and the 1-mg dexamethasone suppression test as well as long-term clinical observation, CS was confirmed in 93 patients and ruled out for the remaining 284. Results: Patients were referred for 18 key symptoms, of which 5 were more common in patients with CS than in those in whom CS was ruled out: osteoporosis (8% vs 2%; P = .02), adrenal incidentaloma (17% vs 8%, P = 0.01), metabolic syndrome (11% vs 4%; P = .02), myopathy (10% vs 2%; P < .001), and presence of multiple symptoms (16% vs 1%; P < .001). Obesity was more common in patients in whom CS was ruled out (30% vs 4%, P < .001), but recent weight gain was prominent in those with CS. A total of 68 of 93 patients with CS (73%) had typical chief complaints, as did 106 of 284 of patients with ruled-out CS status (37%) according to the Endocrine Society practice guideline 2008. Conclusion: The 2008 Endocrine Society Practice guideline for screening and diagnosis of CS defined at-risk populations that should undergo testing. These recommendations are still valid in 2022.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgac379

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Patient selection figure created with BioRender.com.
Figure 1. Patient selection figure created with BioRender.com.CC BY-NC-ND · PubMed Central
Figure 2. Reasonable screening for Cushing syndrome (CS). OR, odds ratio.
Figure 2. Reasonable screening for Cushing syndrome (CS). OR, odds ratio.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 52

Metadata

Authors
Braun, L. T., Vogel, F., Zopp, S., Marchant Seiter, T., Rubinstein, G., Berr, C. M., Künzel, H., Beuschlein, F., & Reincke, M.
Affiliations
  • LMU Klinikum (DE)
  • Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München , 80336 Munich , Germany
  • University of Augsburg (DE)
  • University of Zurich (CH)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2022-06-22
Volume
107
Issue
9
Pages
e3723-e3730
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4283326364
Cited by
52
References
51
Citations by year
2026: 9 · 2025: 14 · 2024: 14 · 2023: 11 · 2022: 4
FWCI
7.97
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (acceptedVersion)
  • OPUS (Augsburg University) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Deutsche Forschungsgemeinschaft (314061271-TRR 205)
  • Clinician Scientist Program RISE
  • Else-Kröner-Fresenius Stiftung
  • Eva Luise und Horst Köhler Stiftung
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
Cushing's syndrome, screening, vulnerable populations, chief complaint, urinary free cortisol, late-night salivary cortisol, dexamethasone suppression test, adrenal incidentaloma, osteoporosis, metabolic syndrome, obesity, myopathy
MeSH terms
Adrenal Gland Neoplasms, Cushing Syndrome, Dexamethasone, Humans, Hydrocortisone, Prospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited. https://app.cochat.ai/papers/10.1210/clinem/dgac379
The paper
Braun, L. T., Vogel, F., Zopp, S., Marchant Seiter, T., Rubinstein, G., Berr, C. M., Künzel, H., Beuschlein, F., & Reincke, M. (2022). Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.